Decision details
Quarter 4 Monitoring Report - HSCP22.032
Decision status: Recommendations approved
Is Key decision?: No
Is subject to call in?: No
Decision:
(i) to note that the Chief Finance Officer would circulate further detail regarding Directorate overspend;
(ii) to instruct the Chief Officer to ask the Moray IJB for an update regarding G-Med;
(iii) to note the report in relation to the IJB budget;
(iv) to note the information on areas of risk and management action; and
(v) to approve the budget virements indicated in Appendix F of the report.
Publication date: 04/05/2022
Date of decision: 26/04/2022
Decided at meeting: 26/04/2022 - Risk, Audit and Performance Committee
Accompanying Documents:
- HSCP.22.032_Qtr4_Financial_Monitoring Update_V2 PDF 412 KB
- HSCP.22.032_Appendix A_IJB P12 Joint Report Final 22.04.2022 PDF 125 KB
- HSCP.22.032_Appendix B IJB P12 Joint Report Final 22.04.2022 PDF 57 KB
- HSCP.22.032_Appendix C_IJB P12 Joint Report Final 22.04.2022 PDF 13 KB
- HSCP.22.032_Appendix D IJB P12 Joint Report Final 22.04.2022 PDF 45 KB
- HSCP.22.032_Appendix E IJB P12 Joint Report Final 22.04.2022 PDF 12 KB
- HSCP.22.032_Appendix F_IJB P12 Joint Report Final 22.04.2022 PDF 99 KB
- HSCP.22.032_Appendix G IJB P12 Joint Report Final 22.04.2022 PDF 59 KB